Chemours
429 hedge funds and large institutions have $1.59B invested in Chemours in 2025 Q4 according to their latest regulatory filings, with 78 funds opening new positions, 120 increasing their positions, 123 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4.31% less ownership
Funds ownership: 94.28% → 89.97% (-4.3%)
29% less capital invested
Capital invested by funds: $2.24B → $1.59B (-$645M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
429
Holding in Top 10
4
Calls
$63.3M
Puts
$26.6M
Top Buyers
| 1 | +$15.9M | |
| 2 | +$13.9M | |
| 3 | +$13.5M | |
| 4 |
D.E. Shaw & Co
New York
|
+$10.2M |
| 5 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
+$9.45M |
Top Sellers
| 1 | -$28.9M | |
| 2 | -$19.9M | |
| 3 | -$18.1M | |
| 4 |
WHCM
Wolf Hill Capital Management
Greenwich,
Connecticut
|
-$17M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$15M |
